Mesothelioma Cancer Resources Blog

When President Obama opened the doors to trade with Cuba this year, he gave the U.S. access to a promising lung cancer vaccine developed in Cuba. The country has developed the first vaccine, being called a “game changer,” shown to be effective against lung cancer. Now, many oncologists and mesothelioma specialists are watching closely in …

Another pharmaceutical company is dedicating resources to help find an effective treatment for mesothelioma. Its efforts have led to an Orphan Drug Designation from the U.S. Food and Drug Administration, and comes on the heels of CRS-207 and tremelimumab, two other drugs developed to make a difference for mesothelioma patients, receiving the same designation from …

Memorial Sloan-Kettering Cancer Center (MSKCC) is breaking the mold with a new type of clinical trial, known as a “basket study.” Whereas traditional trials target a particular cancer, MSKCC is leading the way by offering clinical trials for anti-cancer drugs that focus on a specific biomarker or genetic mutation, regardless of the type of cancer. …